Cunnane Deirdre A. 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Sep 11, 2018
Insider Transaction Report
Form 4
Cunnane Deirdre A.
SVP, General Counsel
Transactions
- Award
Stock Option (right to buy)
2018-09-07+150,000→ 150,000 totalExercise: $0.71Exp: 2028-09-06→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 7, 2018 and is subject to vesting over a two year period, with 50% of the shares vesting on the first anniversary of September 7, 2018 and the remainder vesting over the ensuing year at a rate of 4.1667% per month.